MetaCap

Basel Medical Group (BMGL) vs LifeMD (LFMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

LifeMD is the larger company by market cap ($134.6 million vs $5.2 million), about 25.9 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

BMGL versus LFMD key metrics
MetricBMGLLFMD
Share price$3.28$2.79
Market cap$5.19M$134.63M
1-day change+2.18%+2.20%
YTD return—-18.18%
1-year return—-57.92%
5-year return—-46.14%
Forward P/E—7.34
EPS (TTM)$-4.98$-0.51
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$21.72$6.69
52-week low$2.95$2.56
Distance from 52-week high-84.90%-58.30%
Average volume537.93K841.67K
Shares outstanding1.58M48.26M
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • LifeMD is about 25.9 times larger than Basel Medical Group by market value ($134.63M vs $5.19M).

BMGL vs LFMD FAQ

Which is bigger, Basel Medical Group or LifeMD?

LifeMD (LFMD) is larger, with a market capitalization of $134.63M compared with $5.19M for Basel Medical Group (BMGL).

Are Basel Medical Group and LifeMD in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons